Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Shares Issued (2024 - 2025)

Beta Bionics' Shares Issued history spans 2 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 5208.11% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $4.8 million, up 5244.94%, while the annual FY2025 figure was $4.8 million, 5244.94% up from the prior year.
  • Shares Issued for Q4 2025 was $2.0 million at Beta Bionics, up from -$12.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $15.5 million in Q2 2025 and bottomed at -$12.8 million in Q3 2025.